1. Home
  2. HEPS vs EVO Comparison

HEPS vs EVO Comparison

Compare HEPS & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo D-Market Electronic Services & Trading

HEPS

D-Market Electronic Services & Trading

HOLD

Current Price

$2.68

Market Cap

948.0M

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.96

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HEPS
EVO
Founded
2000
1993
Country
Turkey
Germany
Employees
N/A
4553
Industry
Catalog/Specialty Distribution
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
948.0M
934.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
HEPS
EVO
Price
$2.68
$2.96
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$3.07
$7.00
AVG Volume (30 Days)
266.4K
97.0K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$41.29
$1.37
Revenue Next Year
$27.99
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.15
$2.31
52 Week High
$3.30
$4.80

Technical Indicators

Market Signals
Indicator
HEPS
EVO
Relative Strength Index (RSI) 37.55 47.30
Support Level $2.66 $2.88
Resistance Level $2.95 $3.78
Average True Range (ATR) 0.07 0.12
MACD -0.01 -0.03
Stochastic Oscillator 7.50 13.73

Price Performance

Historical Comparison
HEPS
EVO

About HEPS D-Market Electronic Services & Trading

D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues and other revenues.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: